Jan David1, Petr Chrastina2, Hana Vinohradska3, Eva Al Taji4, Andrea Holubova5, Eva Hlidkova6, Viktor Kozich2, Felix Votava4. 1. Department of Children and Adolescents, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Srobarova 1150/50, 100 34, Prague 10, Czech Republic. jan.david@fnkv.cz. 2. Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital, Ke Karlovu 455/2, Prague, Czech Republic. 3. Department of Clinical Biochemistry, Faculty of Medicine, Masaryk University and University Hospital Brno, Jihlavska 20, Brno, Czech Republic. 4. Department of Children and Adolescents, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Srobarova 1150/50, 100 34, Prague 10, Czech Republic. 5. Department of Biology and Medical Genetics, Second Faculty of Medicine, Charles University and University Hospital Motol, V Uvalu 84, Prague, Czech Republic. 6. Department of Clinical Biochemistry, Faculty of Medicine, Palacky University and University Hospital Olomouc, I. P. Pavlova 185/6, Olomouc, Czech Republic.
Abstract
Neonates with low birthweight (LBW) represent a vulnerable population. This retrospective study analyzed the birth frequency of diseases detected by neonatal screening (NBS) in normal and LBW neonates in the Czech Republic. Between years 2002 and 2016, the number of screened disorders in the Czech Republic gradually increased from two to 13. Prevalence of screened diseases was calculated for cohorts ranging from 777,100 to 1,277,283 neonates stratified by birthweight. Odds ratio of the association of LBW with each disease was calculated and statistical significance was evaluated using the chi-square test or Fisher's exact test, as appropriate. Three diseases were associated with higher risk of prevalence in LBW neonates, namely congenital hypothyroidism (OR 2.50, CI 1.92; 3.25), cystic fibrosis (OR 2.44, CI 1.51; 3.94), and long chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD) (OR 7.74, CI 2.18; 27.42). Conclusion: Although the underlying mechanisms are not well understood, results can be hypothesized that LBW (respectively prematurity) may lead to the secondary and often transitory hypothyroidism while cystic fibrosis and LCHADD may manifest already prenatally and result into preterm birth and LBW. What is Known: • The percentage of low birthweight (LBW) neonates in the Czech Republic has been increasing. • Previously published studies reported positive association between LBW and congenital hypothyroidism and cystic fibrosis. What is New: • The association between LCHADD and LBW has not yet been described. • LBW can be the first manifestation of cystic fibrosis and LCHADD.
Neonates with low birthweight (LBW) represent a vulnerable population. This retrospective study analyzed the birth frequency of diseases detected by neonatal screening (NBS) in normal and LBW neonates in the Czech Republic. Between years 2002 and 2016, the number of screened disorders in the Czech Republic gradually increased from two to 13. Prevalence of screened diseases was calculated for cohorts ranging from 777,100 to 1,277,283 neonates stratified by birthweight. Odds ratio of the association of LBW with each disease was calculated and statistical significance was evaluated using the chi-square test or Fisher's exact test, as appropriate. Three diseases were associated with higher risk of prevalence in LBW neonates, namely congenital hypothyroidism (OR 2.50, CI 1.92; 3.25), cystic fibrosis (OR 2.44, CI 1.51; 3.94), and long chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD) (OR 7.74, CI 2.18; 27.42). Conclusion: Although the underlying mechanisms are not well understood, results can be hypothesized that LBW (respectively prematurity) may lead to the secondary and often transitory hypothyroidism while cystic fibrosis and LCHADD may manifest already prenatally and result into preterm birth and LBW. What is Known: • The percentage of low birthweight (LBW) neonates in the Czech Republic has been increasing. • Previously published studies reported positive association between LBW and congenital hypothyroidism and cystic fibrosis. What is New: • The association between LCHADD and LBW has not yet been described. • LBW can be the first manifestation of cystic fibrosis and LCHADD.
Authors: Olaf Sommerburg; Veronika Krulisova; Jutta Hammermann; Martin Lindner; Mirjam Stahl; Martina Muckenthaler; Dirk Kohlmueller; Margit Happich; Andreas E Kulozik; Felix Votava; Miroslava Balascakova; Veronika Skalicka; Marina Stopsack; Manfred Gahr; Milan Macek; Marcus A Mall; Georg F Hoffmann Journal: J Cyst Fibros Date: 2013-07-25 Impact factor: 5.482
Authors: Felix Votava; Dana Novotna; Petr Kracmar; Hana Vinohradska; Eva Stahlova-Hrabincova; Zuzana Vrzalova; David Neumann; Jana Malikova; Jan Lebl; Dietrich Matern Journal: Eur J Pediatr Date: 2012-01-11 Impact factor: 3.183
Authors: Bijay Vaidya; Viv Campbell; John H Tripp; Gill Spyer; Andrew T Hattersley; Sian Ellard Journal: Clin Endocrinol (Oxf) Date: 2004-06 Impact factor: 3.478